The effect of continuous positive airway pressure on blood pressure in patients with obstructive sleep apnea and uncontrolled hypertension - Study design and challenges during the COVID-19 pandemic

Fernanda C S G Cruz, Luciano F Drager, Daniel B C Queiróz, Gabriela A Souza, Rodrigo P Pedrosa, Tarcya L G Couto Patriota, Egidio L Dórea, Marcelo Luiz C Vieira, Camila G Righi, Denis Martinez, Geruza A da Silva, Giovanio V Silva, Andrea Pio-Abreu, Paulo A Lotufo, Isabela M Benseãor, Luiz A Bortolotto, Flávio D Fuchs, Geraldo Lorenzi-Filho, Fernanda C S G Cruz, Luciano F Drager, Daniel B C Queiróz, Gabriela A Souza, Rodrigo P Pedrosa, Tarcya L G Couto Patriota, Egidio L Dórea, Marcelo Luiz C Vieira, Camila G Righi, Denis Martinez, Geruza A da Silva, Giovanio V Silva, Andrea Pio-Abreu, Paulo A Lotufo, Isabela M Benseãor, Luiz A Bortolotto, Flávio D Fuchs, Geraldo Lorenzi-Filho

Abstract

Objectives: To describe the MORPHEOS (Morbidity in patients with uncontrolled HTN and OSA) trial, and describe the challenges imposed by the COVID-19 pandemic.

Methods: MORPHEOS is a multicenter (n=6) randomized controlled trial designed to evaluate the blood pressure (BP) lowering effects of treatment with continuous positive airway pressure (CPAP) or placebo (nasal strips) for 6 months in adult patients with uncontrolled hypertension (HTN) and moderate-to-severe obstructive sleep apnea (OSA). Patients using at least one antihypertensive medication were included. Uncontrolled HTN was confirmed by at least one abnormal parameter in the 24-hour ABPM and ≥80% medication adherence evaluated by pill counting after the run-in period. OSA was defined by an apnea-hypopnea index ≥15 events/hours. The co-primary endpoints are brachial BP (office and ambulatory BP monitoring, ABPM) and central BP. Secondary outcomes include hypertension-mediated organ damage (HMOD) to heart, aorta, eye, and kidney. We pre-specified several sub-studies from this investigation. Visits occur once a week in the first month and once a month thereafter. The programmed sample size was 176 patients but the pandemic prevented this final target. A post-hoc power analysis will be calculated from the final sample. ClinicalTrials.gov: NCT02270658.

Results: The first 100 patients are predominantly males (n=69), age: 52±10 years, body mass index: 32.7±3.9 kg/m2 with frequent co-morbidities.

Conclusions: The MORPHEOS trial has a unique study design including a run-in period; pill counting, and detailed analysis of hypertension-mediated organ damage in patients with uncontrolled HTN that will allow clarification of the impact of OSA treatment with CPAP.

Conflict of interest statement

No potential conflict of interest was reported.

Figures

Figure 1. Flow chart.
Figure 1. Flow chart.

References

    1. Drager LF, Togeiro ST, Polotsky VY, Lorenzi-Filho G. Obstructive sleep apnea: a cardiometabolic risk in obesity and the metabolic syndrome. J Am Coll Cardiol. 2013;62(7):569–76. doi: 10.1016/j.jacc.2013.05.045.
    1. Peppard PE, Young T, Barnet JH, Palta M, Hagen EW, Hla KM. Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol. 2013;177(9):1006–14. doi: 10.1093/aje/kws342.
    1. Sjöström C, Lindberg E, Elmasry A, Hägg A, Svärdsudd K, Janson C. Prevalence of sleep apnoea and snoring in hypertensive men: a population based study. Thorax. 2002;57(7):602–7. doi: 10.1136/thorax.57.7.602.
    1. Pedrosa RP, Drager LF, Gonzaga CC, Sousa MG, de Paula LKG, Amaro AC, et al. Obstructive sleep apnea: the most common secondary cause of hypertension associated with resistant hypertension. Hypertension. 2011;58(5):811–7. doi: 10.1161/HYPERTENSIONAHA.111.179788.
    1. Sánchez-de-la-Torre M, Campos-Rodriguez F, Barbé F. Obstructive sleep apnoea and cardiovascular disease. Lancet Respir Med. 2013;1(1):61–72. doi: 10.1016/S2213-2600(12)70051-6.
    1. Marin JM, Agusti A, Villar I, Forner M, Nieto D, Carrizo SJ, et al. Association between treated and untreated obstructive sleep apnea and risk of hypertension. JAMA. 2012;307(20):2169–76. doi: 10.1001/jama.2012.3418.
    1. Gottlieb DJ, Yenokyan G, Newman AB, O’Connor GT, Punjabi NM, Quan SF, et al. Prospective study of obstructive sleep apnea and incident coronary heart disease and heart failure: the sleep heart health study. Circulation. 2010;122(4):352–60. doi: 10.1161/CIRCULATIONAHA.109.901801.
    1. Basner RC. Continuous positive airway pressure for obstructive sleep apnea. N Engl J Med. 2007;356(17):1751–8. doi: 10.1056/NEJMct066953.
    1. Fatureto-Borges F, Lorenzi-Filho G, Drager LF. Effectiveness of continuous positive airway pressure in lowering blood pressure in patients with obstructive sleep apnea: a critical review of the literature. Integr Blood Press Control. 2016;9:43–7. doi: 10.2147/IBPC.S70402.
    1. Whelton PK. 2017 ACC / AHA / AAPA / ABC / ACPM / AGS / APhA / ASH / ASPC / NMA / PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. Hypertension. 2017;1:54–5.
    1. Hoyos CM, Yee BJ, Wong KK, Grunstein RR, Phillips CL. Treatment of Sleep Apnea With CPAP Lowers Central and Peripheral Blood Pressure Independent of the Time-of-Day: A Randomized Controlled Study. Am J Hypertens. 2015;28(10):1222–8. doi: 10.1093/ajh/hpv023.
    1. Roman MJ, Devereux RB, Kizer JR, Lee ET, Galloway JM, Ali T, et al. Central pressure more strongly relates to vascular disease and outcome than does brachial pressure: the Strong Heart Study. Hypertension. 2007;50(1):197–203. doi: 10.1161/HYPERTENSIONAHA.107.089078.
    1. Yagihara F, Lorenzi-Filho G, Santos-Silva R. Nasal Dilator Strip is an Effective Placebo Intervention for Severe Obstructive Sleep Apnea. J Clin Sleep Med. 2017;13(2):215–21. doi: 10.5664/jcsm.6450.
    1. Jenner R, Fatureto-Borges F, Costa-Hong V, Lopes HF, Teixeira SH, Marum E, et al. Association of obstructive sleep apnea with arterial stiffness and nondipping blood pressure in patients with hypertension. J Clin Hypertens (Greenwich) 2017;19(9):910–8. doi: 10.1111/jch.13008.
    1. Aielo AN, Santos RB, Silva WA, Parise BK, Souza SP, Cunha LF, et al. Pragmatic Validation of Home Portable Sleep Monitor for diagnosing Obstructive Sleep Apnea in a non-referred population: The ELSA-Brasil study . Sleep Sci. 2019;12(2):65–71. doi: 10.5935/1984-0063.20190072.
    1. Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991;14(6):540–5. doi: 10.1093/sleep/14.6.540.
    1. Danzi-Soares NJ, Genta PR, Nerbass FB, Pedrosa RP, Soares FS, César LA, et al. Obstructive sleep apnea is common among patients referred for coronary artery bypass grafting and can be diagnosed by portable monitoring. Coron Artery Dis. 2012;23(1):31–8. doi: 10.1097/MCA.0b013e32834df5d0.
    1. Uchôa CHG, Pedrosa RP, Javaheri S, Geovanini GR, Carvalho MMB, Torquatro ACS, et al. OSA and Prognosis After Acute Cardiogenic Pulmonary Edema: The OSA-CARE Study. Chest. 2017;152(6):1230–8. doi: 10.1016/j.chest.2017.08.003.
    1. Chowdhuri S, Quan SF, Almeida F, Ayappa I, Batool-Anwar S, Budhiraja R, et al. An Official American Thoracic Society Research Statement: Impact of Mild Obstructive Sleep Apnea in Adults. Am J Respir Crit Care Med. 2016;193(9):e37–54. doi: 10.1164/rccm.201602-0361ST.
    1. Pauca AL, O’Rourke MF, Kon ND. Prospective evaluation of a method for estimating ascending aortic pressure from the radial artery pressure waveform. Hypertension. 2001;38(4):932–7. doi: 10.1161/hy1001.096106.
    1. Costa-Hong VA, Muela HCS, Macedo TA, Sales ARK, Bortolotto LA. Gender differences of aortic wave reflection and influence of menopause on central blood pressure in patients with arterial hypertension. BMC Cardiovasc Disord. 2018;18(1):123. doi: 10.1186/s12872-018-0855-8.
    1. Casey DP, Curry TB, Joyner MJ, Charkoudian N, Hart EC. Relationship between muscle sympathetic nerve activity and aortic wave reflection characteristics in young men and women. Hypertension. 2011;57(3):421–7. doi: 10.1161/HYPERTENSIONAHA.110.164517.
    1. Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN, et al. Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Circulation. 2005;111(5):697–716. doi: 10.1161/01.CIR.0000154900.76284.F6.
    1. Genta-Pereira DC, Furlan SF, Omote DQ, Giorgi DMA, Bortolotto LA, Lorenzi-Filho G, et al. Nondipping Blood Pressure Patterns Predict Obstructive Sleep Apnea in Patients Undergoing Ambulatory Blood Pressure Monitoring. Hypertension. 2018;72(4):979–85. doi: 10.1161/HYPERTENSIONAHA.118.11525.
    1. Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015;28(1):1–39.e14. doi: 10.1016/j.echo.2014.10.003.
    1. Zoghbi WA, Adams D, Bonow RO, Enriquez-Sarano M, Foster E, Grayburn PA, et al. Recommendations for Noninvasive Evaluation of Native Valvular Regurgitation: A Report from the American Society of Echocardiography Developed in Collaboration with the Society for Cardiovascular Magnetic Resonance. J Am Soc Echocardiogr. 2017;30(4):303–71. doi: 10.1016/j.echo.2017.01.007.
    1. Krieger EM, Drager LF, Giorgi DMA, Pereira AC, Barreto-Filho JAS, Nogueira AR, et al. Spironolactone Versus Clonidine as a Fourth-Drug Therapy for Resistant Hypertensio: The ReHOT Randomized Study (Resistant Hypertension Optimal Treatment. Hypertension. 2018;71(4):681–90. doi: 10.1161/HYPERTENSIONAHA.117.10662.
    1. Masa JF, Jiménez A, Durán J, Capote F, Monasterio C, Mayos M, et al. Alternative methods of titrating continuous positive airway pressure: a large multicenter study. Am J Respir Crit Care Med. 2004;170(11):1218–24. doi: 10.1164/rccm.200312-1787OC.
    1. Pengo MF, Soranna D, Giontella A, Perger E, Mattaliano P, Schwarz EI, et al. Obstructive sleep apnoea treatment and blood pressure: which phenotypes predict a response? A systematic review and meta-analysis. Eur Respir J. 2020;55(5):1901945. doi: 10.1183/13993003.01945-2019.
    1. Pedrosa RP, Drager LF, de Paula LKG, Amaro ACS, Bortolotto LA, Lorenzi-Filho G. Effects of OSA treatment on BP in patients with resistant hypertension: a randomized trial. Chest. 2013;144(5):1487–94. doi: 10.1378/chest.13-0085.
    1. Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Hear J. 2018;39(33):3021–104. doi: 10.1093/eurheartj/ehy339.
    1. McEniery CM, Cockcroft JR, Roman MJ, Franklin SS, Wilkinson IB. Central blood pressure: current evidence and clinical importance. Eur Hear J. 2014;35(26):1719–25. doi: 10.1093/eurheartj/eht565.
    1. Ohte N, Saeki T, Miyabe H, Sakata S, Mukai S, Hayano J, et al. Relationship between blood pressure obtained from the upper arm with a cuff-type sphygmomanometer and central blood pressure measured with a catheter-tipped micromanometer. Heart Vessels. 2007;22(6):410–5. doi: 10.1007/s00380-007-0998-5.
    1. ReHOT Investigators, Krieger EM, Drager LF, Giorgi DM, Krieger JE, Pereira AC, et al. Resistant hypertension optimal treatment trial: a randomized controlled trial. Clin Cardiol. 2014;37(1):1–6. doi: 10.1002/clc.22228.
    1. Koga S, Ikeda S, Nakata T, Yasunaga T, Maemura K. Effects of nasal continuous positive airway pressure on left ventricular concentric hypertrophy in obstructive sleep apnea syndrome. Intern Med. 2012;51(20):2863–8. doi: 10.2169/internalmedicine.51.8062.

Source: PubMed

スポンサーと協力者

医学的状態

薬物療法

3
購読する